Five members of Congress, three from the House and two from the Senate, have not been seen or heard from since May 13. Their absence brought several legislative efforts to an immediate halt. House Speaker Mike Johnson postponed a critical vote on the National Defense Authorization Act, while Senate Banking Committee Chair Sherrod Brown delayed a markup for the Stablecoin TRUST Act. This legislative freeze impacts bills worth hundreds of billions of dollars.
The disruption forces K Street to scramble. Lobbying firms representing major tech, defense and financial interests are reassessing their influence campaigns. Companies like Circle, which spent $1.1 million on stablecoin advocacy in the first quarter, now face an uncertain path for their preferred legislation. Defense contractors, including Lockheed Martin and Raytheon, saw their lobbying efforts for specific appropriations suddenly stall. Their ability to push bills through hinges on the return of these members or a shift in committee composition.
Speaker Johnson faces new challenges in maintaining a slim House majority, now effectively reduced to a single-digit margin for floor votes. The absence of three Republican representatives makes passing any contested bill nearly impossible without significant bipartisan support, a rare feat. On the Senate side, Majority Leader Mitch McConnell now commands an even tighter margin, impacting judicial nominations and budget negotiations. This situation empowers a small bloc of centrist senators, giving them influence over stalled legislation.
The Digital Asset Clarity Act, a bipartisan crypto bill, was scheduled for a House Financial Services Committee markup on May 15. The bill, backed by firms like a16z Crypto and Coinbase, required a minimum of 27 votes to advance. The committee now lacks a quorum, effectively killing any near-term progress on comprehensive crypto regulation. This uncertainty saw Bitcoin drop 2.2 percent to $78,992, reflecting broader market anxiety over regulatory delays. Banking stocks also reacted, with the Russell 2000 falling 2.4 percent, as regulatory clarity remains elusive for new financial products.
